Hong Kong-based drug discovery and development company Insilico has secured fresh capital at a time that its CEO described as a “biotech winter.” The firm has raised $35 million on […]
Alex Zhavoronkov
Trending topics and news from the Alex Zhavoronkov category
Back to news home